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Abstract
Background: Clinical practice guidelines are recommendations systematically developed to assist clinical decision-
making and inform healthcare. In current rheumatoid arthritis (RA) guidelines, management of the foot and ankle is
under-represented and the quality of recommendation is uncertain. This study aimed to identify and critically
appraise clinical practice guidelines for foot and ankle management in RA.
Methods: Guidelines were identified electronically and through hand searching. Search terms ‘rheumatoid arthritis’,
‘clinical practice guidelines’ and related synonyms were used. Critical appraisal and quality rating were conducted
using the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument.
Results: Twenty-four guidelines were included. Five guidelines were high quality and recommended for use. Five
high quality and seven low quality guidelines were recommended for use with modifications. Seven guidelines
were low quality and not recommended for use. Five early and twelve established RA guidelines were
recommended for use. Only two guidelines were foot and ankle specific. Five recommendation domains were
identified in both early and established RA guidelines. These were multidisciplinary team care, foot healthcare
access, foot health assessment/review, orthoses/insoles/splints, and therapeutic footwear. Established RA guidelines
also had an ‘other foot care treatments’ domain.
Conclusions: Foot and ankle management for RA features in many clinical practice guidelines recommended for
use. Unfortunately, supporting evidence in the guidelines is low quality. Agreement levels are predominantly ‘expert
opinion’ or ‘good clinical practice’. More research investigating foot and ankle management for RA is needed prior
to inclusion in clinical practice guidelines.
Keywords: Rheumatoid arthritis, Clinical practice guidelines, Foot, Ankle
Abbreviations: AGREE, Appraisal of guidelines for research and evaluation; MeSH, Medical subject heading;
RA, Rheumatoid arthritis
Background
Clinical practice guidelines are systematically developed
recommendations that are used to inform stakeholders
about appropriate healthcare and assist in decision mak-
ing for specific clinical situations [1]. Clinical practice
guidelines provide the basis for evidence-based best
practice in various clinical situations [2]. Furthermore,
guidelines can also help to inform changes to healthcare
policy, as policy makers look for healthcare to be more
efficient and consistent [3]. Whilst having access to
clinical practice guidelines has many benefits, the overall
benefit is only achievable if the guidelines are good qual-
ity [2, 4]. Therefore, appropriate robust methodologies
for developing and appraising guidelines are needed [1].
There is a high prevalence of foot involvement in
rheumatoid arthritis (RA) with over 90 % of patients
reporting foot pain during the course of the disease [5, 6].
Over 60 % of patients report walking disability and foot
involvement impacts negatively on health-related quality
of life [7, 8]. There are many clinical practice guidelines
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currently available specifically related to the management
of RA. The majority are concerned with pharmacological
management of RA. Although, some guidelines take a
more multidisciplinary approach to management, and in-
clude foot and ankle care. However, management of the
foot and ankle in RA is still under-represented in the
overall management of RA. This is unfortunate as foot
and ankle care continues to play a large role in the holistic
management of RA as active disease and associated
symptoms can persist even after reaching clinical remis-
sion [9–11]. Whilst, some foot and ankle care guidelines
are currently available, the quality of these guidelines has
never to our knowledge been appraised.
Therefore, the aim of this review was to identify and
critically appraise clinical practice guidelines that




Guidelines were identified electronically in the follow-
ing databases: Medline (1950 to August 2015),
Embase (1979 to August 2015), CINAHL (1981 to
August 2015), AMED (1987 to August 2015), PEDro
(1990 to August 2015), and the Cochrane Library
(1974 to August 2015). Guidelines were also identified
by hand searching the reference lists of the
electronically identified studies and the researchers’
own literature databases.
A two-way search strategy was employed using
‘rheumatoid arthritis’ with ‘clinical practice guidelines’
and related synonyms. Search terms were determined
primarily by the researcher in consultation with aca-
demic supervisors. The search strategy specifically did
not include foot or ankle, and related terms or specific
treatment terms such as podiatry. This was due to many
clinical practice guidelines including foot and ankle care
without this being specifically highlighted in the title or
keywords. Thus, a number of applicable guidelines could
have been missed by the electronic search if the search
strategy was more specific. The search strategy was a
combination of Medical Subject Heading (MeSH) terms
and text-words. MeSH terms were used when available
and text-words were used when MeSH terms were un-
available or when a specific database did not facilitate
the use of MeSH terms. Associated wildcards and trun-
cations for each database were also used. The search
strategy was formulated in Medline and was adapted to
make it applicable to the other databases.
The Search Strategy in Medline (EBSCO) (adapted
for other electronic databases):
1. (MH “Arthritis, Rheumatoid” OR [“Rheumatoid”
AND “Arthritis”])
2. (MH “Guideline” OR MH “Practice Guidelines” OR
“Guidelines” OR “Clinical Practice” OR “Practice”
OR “Management” OR “Treatment” OR
“Intervention” OR MH “Therapy”)
3. 1 AND 2
MH=MeSH Heading
Study selection criteria
Clinical practice guidelines that included foot and ankle
care were selected. This included specific foot and ankle
guidelines and general management guidelines that in-
cluded the foot and ankle. No restriction was placed on
language. No restrictions were imposed on year of publi-
cation. However, only the most recent version of a spe-
cific guideline was included. Any superseded version was
excluded. Additionally, clinical practice guidelines that
involved other rheumatological conditions were included
provided there was specific RA related guideline content.
All foot and ankle clinical practice guidelines were se-
lected for further analysis. No limitations were imposed
on who provided the management. Diagnostic assess-
ment guidelines were also included as assessment is a
vital part of overall management.
The abstracts of all studies found electronically and
through hand searching were compared to the inclusion
criteria. The electronic abstracts were exported from the
databases and collated into a single document in Microsoft
Office Word 2007 (Microsoft Corporation, Redmond,
Washington, USA). This document also had the abstracts
identified by hand searching added to it. The selection of
abstracts (from the aforementioned collated document)
that appeared to meet the inclusion criteria was conducted
by two reviewers (KH and MPMS) independently. For the
abstracts identified by either reviewer (or both reviewers)
that appeared to meet the inclusion criteria, full-text guide-
lines were obtained and compared to the inclusion criteria
independently prior to quality assessment. Only full-text
guidelines were included for quality assessment. Addition-
ally, due to the pragmatic approach of the search, clinical
practice guidelines that were published as books rather than
journal articles were also included.
Quality assessment
Guideline quality was assessed using the Appraisal of
Guidelines for Research and Evaluation (AGREE) II in-
strument. This is an appraisal instrument that assesses
the methodological rigour and transparency used when a
guideline is developed; components of the overall rec-
ommendations; and factors that influence adherence to
the guidelines [12]. This appraisal instrument is the lat-
est version of the original AGREE instrument, which is a
valid and reliable tool for guideline appraisal [13]. It was
originally developed, by an international collaboration,
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through a multi-stage procedure that included item gen-
eration, selection and scaling, field testing and refine-
ment procedures [14]. It is also generally accepted as the
standard for guideline appraisal [15]. The newest
iteration of the AGREE instrument, the AGREE II
instrument, was developed in response to issues that
arose from the original instrument, such as the need for
refinement of the purpose, response scale and instrument
items [13]. Similarly to the original AGREE instrument,
the AGREE II instrument was developed by an inter-
national collaboration through a multi-stage procedure
[13, 16]. Whilst construct validity has been tested and
established [17], the AGREE II instrument has yet to have
been tested for reliability. However, it was decided that the
AGREE II instrument was the appropriate appraisal in-
strument tool due to being the newest version of the
instrument, increased construct validity compare to the
original instrument [17], and the changes made were done
to increase the measurement properties of the instrument
[13, 18]. The AGREE II appraisal instrument is a 23-item
tool where items are divided between six different do-
mains. The six domains are: scope and purpose; stake-
holder involvement; rigour of development; clarity of
presentation; applicability; and editorial independence
[12]. Quality assessment was performed by two reviewers
(KH and MPMS) independently. Any disagreement was
resolved by a third independent reviewer (JW).
Data extraction and evidence grading
The AGREE II instrument, as part of the overall ap-
praisal process, includes a grading system. A seven point
Likert scale of ‘strongly disagree’ to ‘strongly agree’ is
used to grade each individual item of the AGREE II in-
strument. Strongly disagree is awarded when no infor-
mation or poorly reported information is present for a
specific item. Strongly agree is awarded when the quality
of reporting is exceptional and the full criteria and con-
siderations are met. Each domain is scored by combining
all reviewers’ scores for each item and scaling the total
score as a percentage of the maximum possible score
(Fig. 1).
Whilst a quantitative grading can be given to each do-
main and can help to inform whether a guideline should
be recommended for use, no specific criteria for high
and low quality ranking is provided [12]. For this critical
appraisal, overall quality of the guideline was determined
in the same way that each domain was quantified, in that
each domain score was combined and the overall
percentage of the maximum was determined. The deter-
mination of whether a guideline was high or low quality
was informed by the overall quality score and made at
the discretion of the reviewers (following discussion).
High quality guidelines were classified as those that
would be recommended without modifications. Low
quality guidelines were classified as those that would not
be recommended. An intermediate category of recom-
mended with modifications was used when it was
decided (through reviewer discussion) that a guideline
should be recommended for use, provided issues with
the guideline development identified during appraisal
were rectified. Those guidelines that fell within the inter-
mediate category of recommended with modifications
were classified as high or low quality at the discretion of
the reviewers, and this was based on the amount and
type of modifications required.
Results
A total of 3097 clinical practice guidelines were retrieved
using the detailed search strategy. Figure 2 outlines the
flow chart used to identify clinical practice guidelines for
inclusion (adapted from [19]). The inclusion criteria
Fig. 1 Domain score calculation for the AGREE II Instrument Fig. 2 PRISMA literature search flowchart diagram
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were met by 24 guidelines. This was from a total of 46
general clinical practice guidelines identified. Ten guide-
lines were high quality with five of these guidelines rated
high quality, even though modifications need to be made
to them. Of the high quality guidelines that were recom-
mended with modifications, there was a maximum of
two domains identified that required changing for each
guideline. These identified domains were applicability
(as guidance on implementation and cost was omitted),
editorial independence (as competing interests and fund-
ing was omitted), and/or scope and purpose (greater
clarity required). Four of the guidelines were for early
RA and six of the guidelines were for established RA.
Fourteen guidelines were low quality. However, seven of
these guidelines would still be recommended if modifi-
cations were made. There was a maximum of three
domains identified that required changing for each low
quality guideline that was recommended with modifica-
tions. These identified domains were rigour of development
(greater clarification of the process to develop the guide-
lines required), scope and purpose (more depth about the
reason for the guideline needed), clarity of presentation,
stakeholder involvement (as not all stakeholders were
involved in the guideline development), applicability (as
guidance on implementation and cost was omitted), and/or
editorial independence (as competing interests and funding
were omitted). Of the recommended low quality guidelines,
one was for early RA and six were for established RA. Two
guidelines were specifically for foot and ankle management
alone. Within the included general guidelines, foot and
ankle care recommendations only accounted for small sec-
tions of the guidelines, ranging from one sentence to one
page. The individual domain and overall assessments, usage
recommendations, and quality levels are shown in Table 1.
Five recommendation domains were identified for early
RA. They were multidisciplinary team care, access to foot
healthcare, foot health assessment/review, orthoses/insoles/
splints, and therapeutic footwear. Six recommendation
domains were identified for established RA. They were
multidisciplinary team care, access to foot healthcare, foot
health assessment/review, orthoses/insoles/splints, thera-
peutic footwear, and other foot care treatments. The foot
Table 1 Quality assessment of included guidelines
















ACR 2002 [23] 42 % 42 % 34 % 44 % 35 % 58 % 42 % N Low
ARMA 2004 [33] 56 % 78 % 42 % 64 % 44 % 33 % 58 % M Low
Brosseau et al. 2004 [40] 56 % 58 % 63 % 67 % 10 % 38 % 58 % M High
Colebatch et al.2013 [41] 31 % 33 % 61 % 75 % 9 % 58 % 50 % M Low
Combe et al. 2007 [20] 67 % 44 % 56 % 61 % 8 % 13 % 42 % N Low
da Mota et al. 2012 [24] 53 % 33 % 28 % 75 % 15 % 46 % 33 % N Low
DSR 2009 [42] 69 % 78 % 67 % 75 % 56 % 63 % 75 % Y High
Forestier et al. 2009 [43] 56 % 47 % 57 % 78 % 2 % 46 % 42 % M Low
Gossec et al. 2005 [44] 64 % 58 % 56 % 67 % 10 % 17 % 42 % M Low
Gossec et al. 2006 [45] 61 % 36 % 61 % 75 % 0 % 21 % 50 % M Low
Hodkinson et al. 2013 [21] 61 % 64 % 26 % 67 % 27 % 17 % 42 % N Low
Kennedy et al. 2005 [46] 67 % 42 % 44 % 69 % 44 % 75 % 50 % M Low
Luqmani et al. 2006 [47] 89 % 64 % 55 % 75 % 50 % 67 % 67 % Y High
Luqmani et al. 2009 [48] 92 % 64 % 61 % 81 % 56 % 54 % 67 % Y High
NICE 2009 [49] 92 % 86 % 74 % 78 % 65 % 58 % 75 % Y High
Physicians of India 2002 [25] 56 % 31 % 35 % 58 % 8 % 17 % 25 % N Low
PRCA 2008 [34] 61 % 75 % 42 % 69 % 38 % 33 % 58 % M High
RACGP 2009 [50] 86 % 61 % 75 % 75 % 38 % 42 % 58 % M High
Rheum Found Japan 2004 [26] 44 % 36 % 34 % 42 % 13 % 17 % 25 % N Low
Schneider et al. 2011 [51] 67 % 58 % 68 % 69 % 29 % 71 % 67 % Y High
SER 2011 [52] 50 % 39 % 84 % 81 % 25 % 67 % 67 % M High
SIGN 2011 [53] 81 % 72 % 81 % 67 % 50 % 25 % 67 % M High
Walsh et al. 2007 [22] 44 % 56 % 24 % 67 % 29 % 33 % 42 % N Low
Williams et al. 2011 [35] 67 % 56 % 36 % 61 % 31 % 38 % 42 % M Low
Bold % in individual domains are domains requiring modification; Y = Yes; M = Yes with modifications; N = No
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care related recommendations from each guideline recom-
mended for use and the grade of each these recommenda-
tion (based on level of evidence) are described in Table 2
for early RA and Table 3 for established RA.
Low quality guidelines not recommended for use in-
cluded a number of foot care recommendations that
concurred with high quality guidelines or low quality
guidelines that were recommended for use. For early
RA, the recommendations were use of orthoses/insoles/
splints for pain relief [20]. For established RA, the
recommendations were podiatry is part of the multidis-
ciplinary team [21, 22], joint protection with orthoses/
insoles/splints [23–26], and radiographs of the feet on
initial diagnosis and then annually to monitor disease
progression [24]. No foot and ankle care recommenda-
tions were found in the guidelines not recommended for
use that were not also present in guidelines recommended
for use.
Discussion
Foot and ankle care features in many RA management
guidelines, that following appraisal would be recom-
mended for clinical use. Five guidelines were fully rec-
ommended, twelve were recommended with
modifications, and seven were not recommended. There
were four and six high quality guidelines for the man-
agement of early RA and established RA respectively.
There were also one and six recommended low quality
guidelines for early and established RA respectively. Rec-
ommendation domains were multidisciplinary team care,
access to foot healthcare, foot health assessment/review,
orthoses/splints/insoles, therapeutic footwear, and other
foot care treatments. The strength of the grade of rec-
ommendation (based on levels of evidence) for each do-
main was predominantly ‘good clinical practice’. This
was with the exception of foot orthoses and therapeutic
footwear, which had higher grades of recommendation
underpinned by a limited number of systematic reviews
and randomised controlled trials.
Many of the guidelines advocated podiatry as part of
the multidisciplinary team and included specific foot and
ankle management options. This is due to: 1) persistent
foot problems can still occur even after reaching clinical
remission [9–11]; 2) people with increased disease states
may have mechanical foot impairments needing treat-
ment in conjunction with systemic management; and 3)
people who do not respond to or are ineligible for
biological therapy may continue to have active foot in-
volvement [27]. Unfortunately, these guidelines offer no
guidance as to how foot and ankle care should be
incorporated into the multidisciplinary team.
As far as we are aware, this is the only guideline ap-
praisal completed for foot and ankle care as part of RA
management. There is minimal previous work completed
within rheumatology, where only one systematic appraisal
was identified for lower limb osteoarthritis [28] and one
for knee and hip management in osteoarthritis [29]. No
appraisals of guidelines were found for other areas of foot
and ankle care or podiatry.
Clinical practice guidelines need to be appraised for
quality as they are used to inform appropriate healthcare
and assist in clinical decision making [1]. However, this
is only possible if the guidance is good quality [2, 4].
Guidelines that do not meet an appropriate standard
might actually be detrimental to patient health as they
might recommend care that could be harmful. This was
not the case in this appraisal, as non-recommended
guidance concurred with recommended guidelines
meaning these particular recommendations could be
used clinically. However, ideally the recommended
guidelines should be utilised in preference. Additionally,
it should be noted that these are only guidelines, and
health practitioners must be careful not to place too
much emphasis on them [1]. They take time to develop
and newer evidence may become available which is not
included in the guidelines. This consideration is particu-
larly important in this case, as there was variability in
the evidence included in each individual guideline as a
consequence of differing development strategies and
year of publication. Additionally, clinical experience is
still important, especially in areas where limited evidence
is present [2]. This is also seen in the guidelines where
many recommendations are based on ‘good clinical
practice’ or ‘expert opinion’.
The availability of multiple guidelines presents oppor-
tunities for varied use and implementation across clin-
ical practice, and consequently this may impact on the
delivery of care. There is evidence to support this in
podiatry, where guidelines are better known and
understood by those in specialist roles in comparison to
non-specialists [30]. This clinical appraisal presents rec-
ommendations based on quality indicators so may be
useful to standardise the delivery of evidence based care.
High quality guidelines tended to be from government
agencies or established guideline groups. The higher
assessment was most likely due to the more systematic
approach taken to develop the guidelines. This was con-
sistent with a study that looked at the characteristics of
high quality guidelines by evaluating 86 clinical practice
guidelines from eleven different countries [31]. Conversely,
the low quality guidelines were developed by smaller spe-
cialist groups. This was also consistent with another study
that found guidelines developed by specialist groups were
unsatisfactory when critically appraised [32].
Applicability of the guidelines was a low scoring domain
and many of the guidelines that needed modifications
required them in this area. This differed to a study that
found that applicability was decreased in the high quality
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Table 2 Recommended early RA guidelines
Guideline Multidisciplinary team care AAccess to foot healthcare Foot health assessment/review Orthoses/insoles/splints Therapeutic footwear
Clinical practice guidelines for the
use of non-pharmacological
treatments in early rheumatoid
arthritis [45]
Metatarsal pain and/or foot
alignment abnormalities
should be looked for
regularly (GCP)
Appropriate insoles should
be prescribed if needed (GCP)
BSR and BHPR Guidelines for the
management of rheumatoid
arthritis (the first 2 years) [47]





Access to podiatry should be
available according to patient
need (GCP)
Podiatry services should provide
specific and dedicated service for
diagnosis, assessment and
management of foot problems
associated with RA (GCP)
Timely intervention for acute
problems is important (GCP)
Annual foot review and
assessment is recommended for
patients at risk of developing
serious complications in order to
detect problems early (GCP)
Appropriate lower limb
assessment for neurological
and vascular status needed (GCP)
Assessment of lower limb
mechanics and foot pressures
should occur (B)
Orthoses are an important
and effective intervention
in RA (B)
There should be a
provision of specialist
footwear if needed (B)
Clinical guidelines for the diagnosis
and management of early
rheumatoid arthritis [50]
Podiatry is part of the
multidisciplinary team (GCP)
GPs should support access to
appropriate foot care for patients
with RA (GCP)
Annual foot review and
assessment recommended for
patients at risk of developing
serious complications in order to
detect problems early (GCP)
Appropriate foot orthoses are
an important and effective
intervention for RA (B)
Management of early rheumatoid
arthritis [51]






SIGN 123 Management of early
rheumatoid arthritis [53]
Podiatry is part of the
multidisciplinary team (GCP)
‘Good practice’ to offer all patients
with early RA a podiatry referral (GCP)
Some evidence for the efficacy
of foot orthoses for comfort,








A = Grade of recommendation based on systematic reviews; B = Grade of recommendation based on randomised controlled trials; C = Grade of recommendation based on quasi-experimental studies; D = Grade of rec-















Table 3 Recommended guidelines for established RA
Guidelines Multi-disciplinary team care
ARMA Standards of care for people with inflammatory arthritis [33] People with inflammatory arthritis should have ongoing access to local
multi-disciplinary team (GCP)
Podiatry is part of the multi-disciplinary team (GCP)
Ottawa Panel evidence-based clinical practice guidelines for
electrotherapy & thermotherapy interventions in the management
of RA in adults [40]
Structural evaluation in the management of patients with RA:
Development of recommendations for clinical practice based on
published evidence and expert opinion [44]
BSR Guidelines on standards of care for persons with RA [46] Podiatry is part of the multi-disciplinary team (GCP)
Early referral for surgical opinion if required (GCP)
PRCA Standards of care for people with MSK foot health problems [34]
Diagnosis and Treatment of RA [42]
Clinical Practice Guidelines for non-drug treatment (excluding surgery)
in RA [43]
BSR and BHPR Guidelines for the management of RA
(after the first 2 years) [48]
NICE RA National clinical guideline for management and treatment in
adults [49]
Clinical practice guidelines for the management of RA in Spain [52]
NWCEG Guidelines for the management of the foot health problems
associated with RA [35]
Referral for surgery opinion should be offered as an alternative to
therapeutic footwear referral (GCP)
Optimum ulcer management can only be achieved by a holistic and
integrated multi-disciplinary team approach (GCP)
Contact the patient’s consultant/CNS immediately if the patient is being
managed with biologic therapy and develops an ulcer and/or
infection (GCP)
Red flags requiring urgent referral–tendon rupture, septic arthritis, suspicion
of cancer (GCP)
EULAR recommendations for the use of imaging of the joints in the
clinical management of RA [41]
Guidelines Access to foot healthcare
ARMA Standards of care for people with inflammatory arthritis [33] All people with a sudden ‘flare-up in their condition should have direct
access to specialist advice and the option for early review with the
appropriate multi-disciplinary team member (GCP)Ottawa Panel evidence-based clinical practice guidelines for
electrotherapy & thermotherapy interventions in the management
of RA in adults [40]
Structural evaluation in the management of patients with RA:
Development of recommendations for clinical practice based on
published evidence and expert opinion [44]
BSR Guidelines on standards of care for persons with RA [46] When clinically indicated access to podiatry should be available within 6
weeks of referral (GCP)
PRCA Standards of care for people with MSK foot health
problems [34]
Timely access to foot healthcare – diagnosis, assessment and
management (GCP)
Adequate information/education should be given for self-management
and signs/symptoms of deterioration in foot health and need to access
specialist help promptly (GCP)
Diagnosis and Treatment of RA [42]
Clinical Practice Guidelines for non-drug treatment (excluding surgery)
in RA [43]
Every patient with RA should be informed of the rules of foot hygiene and
of potential benefit of referral to a podiatrist (GCP)
A podiatrist should be consulted to treat nail anomalies and hyperkeratoses
on the feet of patients with RA (GCP)
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Table 3 Recommended guidelines for established RA (Continued)
BSR and BHPR Guidelines for the management of RA
(after the first 2 years) [48]
NICE RA National clinical guideline for management and treatment
in adults [49]
All patients with RA and foot problems should have access to a
podiatrist (GCP)
Clinical practice guidelines for the management of RA in Spain [52]
NWCEG Guidelines for the management of the foot health problems
associated with RA [35]
Referral to a podiatrist is an integral part of the early management of
RA patients (GCP)
EULAR recommendations for the use of imaging of the joints in the
clinical management of RA [41]
Guidelines Foot health assessment/review
ARMA Standards of care for people with inflammatory arthritis [33]
Ottawa Panel evidence-based clinical practice guidelines for
electrotherapy & thermotherapy interventions in the management
of RA in adults [40]
Structural evaluation in the management of patients with RA:
Development of recommendations for clinical practice based on
published evidence and expert opinion [44]
Investigations to monitor course of RA should include radiographs of
forefeet and should be done every 6 months in the first year, then every
year to the third year and every 2–4 years thereafter (GCP)
BSR Guidelines on standards of care for persons with RA [46]
PRCA Standards of care for people with MSK foot health
problems [34]
Foot healthcare providers must understand consequences of systemic
disease on the feet and be able to identify warning signs that require
timely referral to specialist medical care (GCP)
Foot health assessment should occur within 3 months of diagnosis–doesn’t
have to be done by foot health specialist (GCP)
Annual review of foot health needs are desirable–doesn’t have to be done
by foot health specialist (GCP)
Where there is substantial change (better/worse) in disease activity,
foot health should be reviewed (GCP)
Diagnosis and Treatment of RA [42]
Clinical Practice Guidelines for non-drug treatment (excluding surgery)
in RA [43]
Feet, footwear and orthoses should be regularly examined (GCP)
BSR and BHPR Guidelines for the management of RA
(after the first 2 years) [48]
NICE RA National clinical guideline for management and treatment in
adults [49]
All patients with RA and foot problems should have access to a podiatrist
for assessment and periodic review of their foot health needs (GCP)
Clinical practice guidelines for the management of RA in Spain [52]
NWCEG Guidelines for the management of the foot health problems
associated with RA [35]
All patients should be referred for foot health assessment with 3 months
of diagnosis with RA (GCP)
All people with RA and foot problems should have access to a podiatrist
for assessment and periodic review of their foot health needs (GCP)
Patients with RA diagnosis should be assessed as soon as possible after
diagnosis for lower limb and foot structural problems (GCP)
EULAR recommendations for the use of imaging of the joints in the
clinical management of RA [41]
Feet x-rays initial imaging technique to detect damage. Ultrasound and/or
MRI should be considered if x-rays do not show damage and may be used
to detect earlier damage (GCP)
MRI or ultrasound detected synovitis and joint damage detected by x-rays,
MRI or ultrasound can be considered for prediction of further joint
damage (C)
Periodic evaluation of joint damage should be considered. MRI
(and possibly ultrasound) can be used to monitor disease progression (C)
MRI and ultrasound detected inflammation predicts subsequent joint
damage, even with clinical remission and can assess persistent
inflammation (C)
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Table 3 Recommended guidelines for established RA (Continued)
Guidelines Orthoses/insoles/splints
ARMA Standards of care for people with inflammatory arthritis [33]
Ottawa Panel evidence-based clinical practice guidelines for electro-
therapy & thermotherapy interventions in the management of RA in
adults [40]
Structural evaluation in the management of patients with RA:
Development of recommendations for clinical practice based on
published evidence and expert opinion [44]
BSR Guidelines on standards of care for persons with RA [46]
PRCA Standards of care for people with MSK foot health problems [34]
Diagnosis and Treatment of RA [42] Insoles may have a beneficial effect on pain in people with RA and foot
complaints (A)
Clinical Practice Guidelines for non-drug treatment (excluding surgery)
in RA [43]
Customised toe splints may be preventive, corrective or palliative to
enable the wearing of shoes (GCP)
Customised orthotic insoles are recommended in the case of weight-bearing
pain or static foot problems (GCP)
Orthoses should be regularly examined (GCP)
Limited evidence for the use of foot orthoses - no consensus regarding
choice of orthoses but reduction of pain and improved function of the
foot are reported (A)
BSR and BHPR Guidelines for the management of RA (after the first
2 years) [48]
Functional insoles should be available to all people with RA if indicated (A)
NICE RA National clinical guideline for management and treatment in
adults [49]
Insoles may have a beneficial effect on pain in people with RA and
foot complaints (A)
Clinical practice guidelines for the management of RA in Spain [52] Hard orthotics improve pain in the hindfoot in the initial phase of
the disease (A)
Use of a special model can prevent the development and progression
of hallux valgus (A)
All patients with RA and foot pain should be considered for foot orthoses
advice, irrespective of disease duration (B)
NWCEG Guidelines for the management of the foot health problems
associated with RA [35]
Patients with established foot deformity should be assessed for
accommodative foot orthoses (C)
Functional foot orthoses should be provided where tarsal joints
are unaffected (B)
Accommodative/cushioned orthoses should be provided when structural
foot deformity, painful symptoms and activity restriction present (C)
EULAR recommendations for the use of imaging of the joints in the
clinical management of RA [41]
Guidelines Therapeutic footwear
ARMA Standards of care for people with inflammatory arthritis [33]
Ottawa Panel evidence-based clinical practice guidelines for electro-
therapy & thermotherapy interventions in the management of RA in
adults [40]
Structural evaluation in the management of patients with RA:
Development of recommendations for clinical practice based on
published evidence and expert opinion [44]
BSR Guidelines on standards of care for persons with RA [46]
PRCA Standards of care for people with MSK foot health
problems [34]
Diagnosis and Treatment of RA [42] Specially selected footwear may have a beneficial effect on pain in people
with RA and foot complaints (B)
Prescribing shoe adjustments and provisions must be considered in
patients with RA and foot complaints (B)
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Table 3 Recommended guidelines for established RA (Continued)
Clinical Practice Guidelines for non-drug treatment (excluding surgery)
in RA [43]
Patients should be advised about footwear (GCP)
Footwear should be regularly examined (GCP)
Extra-width off-the-shelf or therapeutic thermoformed shoes are
recommended when the feet are deformed and painful, if shoes are difficult
to put on, or other footwear types have failed (C)
Such shoes reduce pain on walking and improve functional capacity (GCP)
Palliative customised therapeutic shoes may be prescribed when feet are
seriously affected (GCP)
BSR and BHPR Guidelines for the management of RA (after the first
2 years) [48]
Semi-rigid orthotic supportive shoes can be effective for
metatarsalgia–reduction in pain, disability, and improvement in activity
as measured by the FFI have been reported (B)
NICE RA National clinical guideline for management and treatment in
adults [49]
Therapeutic footwear should be available to all people with RA if
indicated (D)
Clinical practice guidelines for the management of RA in Spain [52] Shoes with extra width improve the result of orthotics (A)
NWCEG Guidelines for the management of the foot health problems
associated with RA [35]
All patients with RA and foot pain should be considered for therapeutic
footwear advice, irrespective of disease duration (B)
Patients with established foot deformity should be assessed for
accommodative footwear advice/specialist footwear (B)
Footwear assessment and advice should be given to all patients (GCP)
Patients struggling with retail footwear due to deformity should be offered
the option of referral for therapeutic footwear. They should be informed of
potential benefits and limitations of this footwear in respect to cosmesis (B)
EULAR recommendations for the use of imaging of the joints in the
clinical management of RA [41]
Guidelines Other treatments
ARMA Standards of care for people with inflammatory arthritis [33]
Ottawa Panel evidence-based clinical practice guidelines for electro-
therapy & thermotherapy interventions in the management of RA in
adults [40]
Low-level laser therapy is beneficial for pain relief in the feet (B)
Structural evaluation in the management of patients with RA:
Development of recommendations for clinical practice based on
published evidence and expert opinion [44]
BSR Guidelines on standards of care for persons with RA [46]
PRCA Standards of care for people with MSK foot health problems [34]
Diagnosis and Treatment of RA [42]
Clinical Practice Guidelines for non-drug treatment (excluding surgery)
in RA [43]
BSR and BHPR Guidelines for the management of RA (after the first
2 years) [48]
NICE RA National clinical guideline for management and treatment in
adults [49]
Clinical practice guidelines for the management of RA in Spain [52]
NWCEG Guidelines for the management of the foot health problems
associated with RA [35]
Callus should be assessed in relations to symptoms and causative factors
before debridement is considered (GCP)
Fungal infections (of the nail and skin) must be investigated and treated. If
left untreated they can lead to ulceration and secondary bacterial infection.
Discussion with the patient’s GP or consultant advised before systemic
treatment is instigated (GCP)
Consultant advice should be taken on ingrown toenails if the patient is
being managed with a biological therapy and where there are signs of
clinical infections and/or need for nail surgery (GCP)
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guidelines as there was more emphasis on development
methodology rather than the effectiveness of the guide-
lines in clinical practice [31]. However, it is difficult to
determine if absence of applicability from the guidelines
was due to applicability not being considered or referral to
it was just simply omitted. Applicability is important as it
includes the feasibility of implementing the guidelines
within the healthcare sector. There is limited benefit in a
guideline advocating particular foot and ankle health rec-
ommendations if it is not feasible for them to be imple-
mented. This could be from financial, staffing or time
perspectives and/or restrictions. This is particularly an
issue currently within the UK National Health Service due
to funding restrictions. On a positive note, many of the
specialist groups did provide good clinical practice points
which can help to standardise delivery of care [33–35].
The stakeholder domain generally scored quite highly.
However, it was noticed during appraisal that patient
involvement was not always present, even though they
are major stakeholders in clinical care and should be
actively involved [36]. Additionally, many of the develop-
ment groups for the recommended guidelines did not
include foot care specialists. This was even though it has
previously been highlighted that including practitioners
in the feasibility and acceptability of guidelines improves
the overall effectiveness of the guideline [37].
Few of the recommended guidelines were specifically
related to early RA. This is even though there has been a
paradigm shift for a more targeted and aggressive ap-
proach that takes advantage of the ‘window of opportun-
ity’ for all management strategies including systemic and
non-pharmacological interventions [27, 38]. However,
the limited number of early RA guidelines including foot
and ankle care may reflect an overall lack of evidence
underpinning proposed paradigm shifts in foot care [39].
It should be noted that two of the guidelines were
classified as standards and did state that they were not
clinical practice guidelines [33, 34]. However, the recom-
mendations in these standards are often implemented
clinically. Additionally, the statement regarding being a
standard and not a guideline was very hard to find
within the documents.
Whilst foot and ankle care recommendations were
taken from the guidelines, the guideline in its entirety
was appraised. The way to determine the percentage
scores for each domain was specified by the AGREE II
instrument. However, the overall score was determined
by the reviewers and was applied in the same numerical
way as each domain score. Overall, in determining qual-
ity of the guidelines, the domain requiring modification
dictated the quality level. The rigour of development do-
main was deemed more important than other domains,
because if modifications were needed for this domain
then the whole guideline would need to be redone com-
pared to small additions being made as modifications for
the other domains. This was why some guidelines were
high quality with modifications compared to low quality
with modifications, even though the overall assessment
score was the same. This was also the case for low qual-
ity guidelines recommended for use with modifications
compared to low quality guidelines not recommended
for use.
The limitations of this critical appraisal mainly related
to the appraisal instrument used. The AGREE II instru-
ment has not been tested for reliability. However, the
predecessor is a valid and reliable instrument, and the
AGREE II instrument has good construct validity and
the changes made to create it were completed to
increase the instrument measurement properties [18].
The use of percentages meant that guidelines may have
had the same overall score. However, this could mean
that a guideline may have had similar scores for each
domain or alternatively, some domains had higher and/
or lower scores than others. Additionally, no guidance
was given with the AGREE II instrument about how to
determine high and low quality. This was decided col-
lectively by the reviewers to reduce bias in the
assessment.
Table 3 Recommended guidelines for established RA (Continued)
Patient education should include foot health self management advice and
if necessary demonstration, explanation of foot problems and their impact
on the individual, information on general disease management and
signposting for future foot health needs (GCP)
Consider steroid injection therapy for targeting localised, inflamed joints
when the general disease is controlled (only in absence of sepsis) (GCP)
Injection therapy should be seen as an adjunct to conventional podiatric
management in combination with attempts to correct any structural
deformity using orthoses (GCP)
EULAR recommendations for the use of imaging of the joints in the
clinical management of RA [41]
A = Grade of recommendation based on systematic reviews; B = Grade of recommendation based on randomised controlled trials; C = Grade of recommendation
based on quasi-experimental studies; D = Grade of recommendation based on non-experimental descriptive studies; GCP = Good Clinical Practice based on
expert opinion
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Only new editions of guidelines were appraised,
which meant that comparisons between different edi-
tions of guidelines was not possible. However, this was
not deemed necessary as newer editions superseded
previous editions. Additionally, another study showed
there is a small amount of improvement over time be-
tween editions [31]. As there was no language restric-
tion for the guidelines, there may have been translation
issues for those not in English. However, one of the re-
viewers was multilingual which helped to reduce issues
with translation.
Conclusion
Many recommendations for foot and ankle care were
present in the clinical practice guidelines that were ap-
praised and recommended for use. This appraisal has
identified a wide breadth of recommendations within
these guidelines, from multidisciplinary team care and
service access to assessment and specific interventions.
Unfortunately, supporting evidence in the guidelines
was low quality overall, with grades of recommenda-
tions predominantly being ‘good clinical practice’ or
‘expert opinion’. Whilst the recommendations identi-
fied show the current minimum clinical standard, more
research investigating foot and ankle management in
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